Stockreport

Seres Therapeutics to Present New Data Supporting SER-109 Clinical Activity at IDWeek 2018

Seres Therapeutics, Inc.  (MCRB) 
Last seres therapeutics, inc. earnings: 11/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.serestherapeutics.com
PDF Findings support SER-109 Phase 3 program as a potential new treatment option for C. difficile infection CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Se [Read more]